Findit, Inc.: BioRegenx Announces Study of Glycocalyx Damage from Kidney Patients' Plasma and Its Restoration with Endocalyx Pro
CHATTANOOGA, TN / ACCESSWIRE / January 4, 2023 / BioRegenx, Inc. which has entered into a Definitive Agreement to merge with Findit, Inc, and its subsidiary Microvascular Health Solutions, LLC (MVHS) based
Source: finanznachrichten.de